SFX by Ex Libris Inc.

Title:	Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2)
Source:	Journal of Medicinal Chemistry [0022-2623] yr:2015

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Magee, Thomas V. "Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening." Bioorganic and medicinal chemistry letters 25.12 (2015): 2461-2468.
description	2.	Wigglesworth, Mark J. "Increasing the delivery of next generation therapeutics from high throughput screening libraries." Current opinion in chemical biology 26 (2015): 104-110.
description	3.	Hawkins, Joel M. "Organic chemistry: Streamlining drug synthesis." Nature 520.7547 (2015): 302-303.
description	4.	Clark, Peter G K G. "LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor." Angewandte Chemie (International ed.) 54.21 (2015): 6217-21.
description	5.	Conway, Stuart J. "Small molecule inhibitors of bromodomain-acetyl-lysine interactions." ACS chemical biology 10.1 (2014): 4294967295-39.
description	6.	Eggers, K. "RAGE-Dependent Regulation of Calcium-Binding Proteins S100A8 and S100A9 in Human THP-1." Experimental and clinical endocrinology & diabetes 119.6 (2011): 353-357.
description	7.	Rossi Sebastiano, M. "Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5." Journal of medicinal chemistry. 61.9: 4189-4202.
description	8.	Lee, J. "Diversity-Oriented Approach for Chemical Biology." Chemical record 15.2 (2015): 495-510.
description	9.	Babiarz, Josephine C. "Confounding Issues in Cancer Progress--The Impact of Investor Requirements on Senior Management Compensation and Regulatory Decisions: Tivozanib and Aveo Pharmaceuticals." Therapeutic innovation & regulatory science 49.3 (2015): 333-341.
description	10.	Albalate, M. "Is it useful to increase dialysate flow rate to improve the delivered Kt?" BMC nephrology 16.1 (2015): 20-20.
description	11.	Picaud, S. "9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain." Journal of medicinal chemistry 58.6 (2015): 2718-2736.
description	12.	Healy, Alan R. "Stereochemical Assignment of the Protein-Protein Interaction Inhibitor JBIR-22 by Total Synthesis." Angewandte Chemie (International ed.) 54.13 (2015): 4046-4050.
description	13.	Núñez, Anna G. "Creation through Immobilization: A New Family of High Performance Heterogeneous Bifunctional Iminophosphorane (BIMP) Superbase Organocatalysts." Organic letters 16.24 (2014): 6294-6297.
description	14.	Shanware, Naval P. "Glutamine deprivation stimulates mTOR-JNK-dependent chemokine secretion." Nature communications 5 (2014): 4900-.
description	15.	Rooney, Timothy P C P. "A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced‐Fit Pocket Stabilized by a Cation–π Interaction." Angewandte Chemie (International ed.) 53.24 (2014): 6126-30.
description	16.	Healy, J. "Understanding the structural requirements for activators of the kef bacterial potassium efflux system." Biochemistry 53.12 (2014): 1982-92.
description	17.	Filippakopoulos, P. "Targeting bromodomains: epigenetic readers of lysine acetylation." Nature reviews. Drug discovery 13.5 (2014): 337-356.
description	18.	Zhang, H. "Application of Continuous Crystallization in an Integrated Continuous Pharmaceutical Pilot Plant." Crystal growth & design 14.5 (2014): 4294967295-2157.
description	19.	Fedorov, O. "[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of diverse bromodomains." Journal of medicinal chemistry 57.2 (2014): 462-476.
description	20.	Lajiness, Jacquelyn D. "Origin, development, and differentiation of cardiac fibroblasts." Journal of molecular and cellular cardiology 70 (2013): 2-8.